Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis

Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples o...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahmood M. T. M. Ally, Bridget Hodkinson, Pieter W. A. Meyer, Eustasius Musenge, Mohammed Tikly, Ronald Anderson
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/183653
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554428295544832
author Mahmood M. T. M. Ally
Bridget Hodkinson
Pieter W. A. Meyer
Eustasius Musenge
Mohammed Tikly
Ronald Anderson
author_facet Mahmood M. T. M. Ally
Bridget Hodkinson
Pieter W. A. Meyer
Eustasius Musenge
Mohammed Tikly
Ronald Anderson
author_sort Mahmood M. T. M. Ally
collection DOAJ
description Matrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P<0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P<0.014–0.0001) and with CRP and SAA levels (r=0.40 and 0.41, resp., P<0.0000) and SDAI (r=0.29, P<0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P<0.001 for both). COMP correlated with smoking, RF, and MMP-3. MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA.
format Article
id doaj-art-7bddb762758b495cbb6da87890d79f7f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-7bddb762758b495cbb6da87890d79f7f2025-02-03T05:51:35ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/183653183653Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid ArthritisMahmood M. T. M. Ally0Bridget Hodkinson1Pieter W. A. Meyer2Eustasius Musenge3Mohammed Tikly4Ronald Anderson5Department of Internal Medicine, Faculty of Health Sciences, University of Pretoria, Private Bag X663, Pretoria 0001, South AfricaDivision of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South AfricaBiostatistics and Epidemiology Division, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaDivision of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service, Pretoria, South AfricaMatrix metalloproteinase-3 (MMP-3) is involved in the immunopathogenesis of rheumatoid arthritis (RA), but little is known about its relationship to genetic susceptibility and biomarkers of disease activity, especially acute phase reactants in early RA. MMP-3 was measured by ELISA in serum samples of 128 disease-modifying, drug-naïve patients and analysed in relation to shared epitope genotype, a range of circulating chemokines/cytokines, acute phase reactants, autoantibodies, cartilage oligomeric protein (COMP), and the simplified disease activity index (SDAI). MMP-3 was elevated >1.86 ng/ml in 56.25% of patients (P<0.0001), correlated with several biomarkers, notably IL-8, IL-6, IFN γ, VEGF and COMP (r values = 0.22–0.33, P<0.014–0.0001) and with CRP and SAA levels (r=0.40 and 0.41, resp., P<0.0000) and SDAI (r=0.29, P<0.0001), but not with erosions or nodulosis. However, the correlations of CRP and SAA with SDAI were stronger (respective values of 0.63 and 0.54, P<0.001 for both). COMP correlated with smoking, RF, and MMP-3. MMP-3 is significantly associated with disease activity, inflammatory mediators and cartilage breakdown, making it a potential biomarker of disease severity, but seemingly less useful than CRP and SAA as a biomarker of disease activity in early RA.http://dx.doi.org/10.1155/2013/183653
spellingShingle Mahmood M. T. M. Ally
Bridget Hodkinson
Pieter W. A. Meyer
Eustasius Musenge
Mohammed Tikly
Ronald Anderson
Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
Mediators of Inflammation
title Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
title_full Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
title_fullStr Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
title_full_unstemmed Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
title_short Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
title_sort serum matrix metalloproteinase 3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis
url http://dx.doi.org/10.1155/2013/183653
work_keys_str_mv AT mahmoodmtmally serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
AT bridgethodkinson serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
AT pieterwameyer serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
AT eustasiusmusenge serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
AT mohammedtikly serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
AT ronaldanderson serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis